
Michael Hallek
Editorial Board at Blood Cancer Journal
Contributor at Future Oncology
Hematologist and oncologist, @UKKoeln & @UniCologne, Germany. Tweets are my own & no medical advice.
Articles
-
2 months ago |
onlinelibrary.wiley.com | Michael Hallek
1 Introduction and Disease Overview In the most recent update of the SEER database, the age-adjusted incidence of chronic lymphocytic leukemia (CLL) was 4.6 per 100 000 inhabitants per year [1], which makes CLL the most common type of leukemia. The median age at diagnosis is 70 years [1]. Less than 10% of patients with CLL are younger than 45 years. More male than female patients (1.9:1) are affected, and this gender effect seems to be stable across all ethnicities.
-
Dec 10, 2024 |
onlinelibrary.wiley.com | Anne Pralong |Michael Hallek |Raymond Voltz |Anja M. Caspers
Data Availability Statement The data generated and analyzed are available upon request. Decisions in terms of data sharing will be made on a case-by-case basis.
-
Feb 5, 2024 |
onlinelibrary.wiley.com | Nadine Kutsch |Philipp Gödel |Conrad-Amadeus Voltin |Michael Hallek
What is the new aspect of your work? Data on patients treated with CAR T-cells for DLBCL-RT are limited in patient numbers and follow-up. To our knowledge, this is our first report of a long-term response of up to 4 years in a patient with DLBCL-RT treated with tisagenlecleucel after aHSCT. What is the central finding of your work? CAR T-cell therapy was feasible in a patient with DLBCL-RT treated with tisagenlecleucel after aHSCT. Grade 2 CRS was manageable with tocilizumab.
-
Oct 23, 2023 |
nature.com | Othman Al-Sawaf |Christian Pallasch |Martin Peifer |Stephan Stilgenbauer |Michael Hallek
Correction to: Nature Communications https://doi.org/10.1038/s41467-023-37648-w, published online 18 April 2023The original version of this article contained an error in the spelling of the author ‘Joseph N. Paulson’, which was incorrectly given as ‘Joe Paulson’. The original version of this article contained an error in Figure 1d, in which the y axis was labeled ‘Cum Progression-free Survival’ rather than ‘Cum Survival’.
-
Oct 23, 2023 |
nature.com | Othman Al-Sawaf |Christian Pallasch |Martin Peifer |Stephan Stilgenbauer |Michael Hallek
Correction to: Nature Communications https://doi.org/10.1038/s41467-023-37648-w, published online 18 April 2023The original version of this article contained an error in the spelling of the author ‘Joseph N. Paulson’, which was incorrectly given as ‘Joe Paulson’. The original version of this article contained an error in Figure 1d, in which the y axis was labeled ‘Cum Progression-free Survival’ rather than ‘Cum Survival’.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 13K
- Tweets
- 2K
- DMs Open
- No